CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 1,470,588 shares at $3.40 ($4,999,999)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 65,000 shares at $3.91 ($254,150)
- 4 Open-market buy President and CEO bought 12,787 shares at $3.91 ($49,997)
- 4 Open-market buy Director bought 12,787 shares at $3.91 ($49,997)
- 4 Open-market buy CFO and Secretary bought 10,000 shares at $3.91 ($39,100)
- 4 Open-market buy Chief Business Officer bought 38,364 shares at $3.91 ($150,003)
- 4 Open-market buy Director bought 38,363 shares at $3.91 ($149,999)
Page 8 of 22 · 429 filings